Clinical Trial Update: Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating HIP2101 for gastritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastritis

Drugs mentioned

• HIP2101

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Gastritis | Phase 3 | Status: COMPLETED